0001660410-17-000002.txt : 20171010 0001660410-17-000002.hdr.sgml : 20171010 20171010122600 ACCESSION NUMBER: 0001660410-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171010 DATE AS OF CHANGE: 20171010 EFFECTIVENESS DATE: 20171010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ribon Therapeutics, Inc. CENTRAL INDEX KEY: 0001660410 IRS NUMBER: 473651475 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296259 FILM NUMBER: 171129649 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING D, SUITE 100 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-914-8700 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING D, SUITE 100 CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001660410 Ribon Therapeutics, Inc. 99 HAYDEN AVENUE BUILDING D, SUITE 100 LEXINGTON MA MASSACHUSETTS 02421 617-914-8700 DELAWARE None None Corporation true 2015 Laurence Lasky 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director Victoria M. Richon 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Jonathan Root 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director Cameron Wheeler 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director David Cordo 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Executive Officer Biotechnology Decline to Disclose 06b false 2017-10-05 false true false 0 20000001 20000001 0 false 8 0 0 0 false Ribon Therapeutics, Inc. /s/ Victoria M. Richon Victoria M. Richon, Ph.D. President and Chief Executive Officer 2017-10-10